BASEC ID Project title Type of project Type of clinical trial Study phase (clinical trials only) multi- / monocentric Category Principal investigator Sponsor Investigational sites Lead EC Local EC(s) Approval date Minors Study Ended
2024-00235 Risk prediction in soft tissue sarcoma using Artificial Intelligence. A retrospective, multicentre study. personal data/biological material monocentric Dr.med. Maria Anna Smolle Universitätsklinik Balgrist Universitätsklinik Balgrist, Zürich
Kantonale Ethikkommission Zürich 18.10.2024
2024-00234 CTQJ230A12203 - A randomized double-blind, placebo-controlled, multi-center trial assessing the impact of lipoprotein(a) lowering with pelacarsen (TQJ230) on the progression of calcific aortic valve s More ... clinical trial drugs phase 2 multicentric C Dr. med. Jonathan Michel Novartis Pharma Schweiz AG Universitätsspital Zürich, Zürich
Universitätsspital Basel, Basel
HUG, Geneve
EOC, Lugano
CHUV, Lausanne
Kantonale Ethikkommission Zürich Ethikkommission Nordwest- und Zentralschweiz EKNZ, Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD), Commission Cantonale d'éthique de la recherche Genève (CCER), Comitat More ... 19.04.2024
2024-00233 A superiority randomized controlled study on the efficacy of radiofrequency for the treatment of women patients with overactive bladder syndrome clinical trial other clinical trials monocentric B PD Dr. med. Andrea Braga Dept. Obstetrics and Gynaecology, EOC - Beata Vergine Hospital Dept. Obstetrics and Gynaecology, EOC - Beata Vergine Hospital, Mendrisio
Comitato etico cantonale Ticino 26.08.2024
2024-00231 Ticin regIstry for caTheter-based treAtments iN patIents with acute pUlmonary eMbolism non clinical, involving persons monocentric A Prof Marco Valgimigli Cardiocentro Ticino Institute, EOC Cardiocentro Ticino Institute, EOC, Lugano, Lugano
Comitato etico cantonale Ticino 14.05.2024
2024-00230 MK-2870-019: A Phase 3 Randomized Open-Label Study of Adjuvant Pembrolizumab With or Without MK-2870 in Participants With Resectable Stage II to IIIB (N2) NSCLC not Achieving pCR After Receiving Neoad More ... clinical trial drugs phase 3 multicentric C PD Dr. med. Michael Mark Merck Sharp & Dohme LLC Kantonsspital Graubünden, Chur
Spital Thurgau AG, Thurgau
HFR hôpital fribourgeois, Fribourg
Centre hospitalier universitaire vaudois (CHUV), Lausanne
Kantonale Ethikkommission Zürich Ethikkommission Ostschweiz (EKOS), Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) 30.04.2024
2024-00229 Biomechanical Evaluation of Various Refixation Techniques Following Extended Trochanteric Osteotomy and Trochanteric Fractures in a Cadaver Model deceased persons monocentric Prof. Dr. med. Patrick Zingg Universitätsklinik Balgrist Universitätsklinik Balgrist, Zürich
Kantonale Ethikkommission Zürich 12.04.2024
2024-00228 TRINITY – Use of commercial human milk samples for in-vitro assays personal data/biological material monocentric Lucile Yart La Société La Société des Produits Nestlé, Lausanne
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) 23.12.2024
2024-00225 Initial experience with Simultaneous Pancreas- and Kidney Transplantations from Donors after Circulatory Death in Switzerland and review of the current literature personal data/biological material monocentric Dr. med. Fabian Rössler Department of Surgery and Transplantation, University Hospital of Zürich University Hospital of Zürich, Zürich
Kantonale Ethikkommission Zürich 26.03.2024
2024-00224 One year results and comparison of two double mobility prostheses for trapeziometacarpal arthritis personal data/biological material monocentric Sebastian Hediger Kantonsspital Frauenfeld Kantonsspital Frauenfeld, Frauenfeld
Ethikkommission Ostschweiz (EKOS) 08.02.2024
2024-00223 Efficacy of Transversus Thoracic Muscle Plane Block in Patients undergoing Cardiac Surgery
A randomized controlled, double blind trial
clinical trial other clinical trials monocentric A PD Dr Sina Grape Hôpital du Valais Service d'Anesthésiologie, Centre Hospitalier du Valais Romand, Sion
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) 30.04.2024 Study has ended
2024-00222 Malleostapedotomy: a 20-year updated review of surgical results personal data/biological material monocentric Prof. Dr. med. Thomas Linder HNO LUKS HNO LUKS, Luzern
Ethikkommission Nordwest- und Zentralschweiz EKNZ 27.02.2024
2024-00220 ADE (adverse drug event) Hospitalization – inadäquate Medikation bei geriatrisch hämatologisch-onkologischen Patientinnen und Patienten personal data/biological material monocentric Dr. med. Wiebke Rösler University Hospital Zurich University Hospital Zurich, Zurich
Kantonale Ethikkommission Zürich 25.06.2024
2024-00219 Clinical, radiological and patient related outcomes in Legg-Calvé-Perthès disease. A monocentric case series non clinical, involving persons monocentric A Dre Sophie Merkaert CHUV - DFME - Chirurgie Hôpital de l’enfance, Centre Hospitalier Universitaire Vaudois, Lausanne
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) 13.05.2024 yes
2024-00218 Evaluation of the electrical and mechanical properties of the glioblastoma microenvironment and the tumor interactions with existing neural circuits personal data/biological material monocentric Prof. Dr. Dr. G. Hutter NCH Basel NCH Basel, Basel
Ethikkommission Nordwest- und Zentralschweiz EKNZ 14.02.2024
2024-00217 Brachytherapy versus surgery in localized squamous cell carcinoma of the lip: a propensity-matched survival analysis non clinical, involving persons monocentric A PD Dr. med. Olgun Elicin Inselspital Universitätsklinik für Radio-Onkologie, Bern
Kantonale Ethikkommission Bern 03.07.2024
2024-00216 Processing Spoken Language and Cognition in Chronic Subjective Tinnitus non clinical, involving persons monocentric A Prof. Dr. rer. nat. Martin Meyer Universität Zürich Universität Zürich, Zürich
Kantonale Ethikkommission Zürich 23.04.2024
2024-00215 CAIN457E22101 - An open-label, multicenter study to evaluate the pharmacokinetics, safety and tolerability of intravenous secukinumab infusion in adults with giant cell arteritis (GCA) or polymyalgia More ... clinical trial drugs phase 1 multicentric C Prof. Dr. med. Thomas Daikeler Novartis Pharma Schweiz AG Universitätsspital Basel, Basel
Inselspital Bern - Universitätsspital, Bern
Kantonsspital St. Gallen, St. Gallen
Ethikkommission Nordwest- und Zentralschweiz EKNZ Ethikkommission Ostschweiz (EKOS), Kantonale Ethikkommission Bern 04.04.2024 Study has ended
2024-00214 DAREON-8: A Phase I, open-label, dose escalation and expansion trial of repeated intravenous infusions of BI 764532 combined with standard of care (platinum, etoposide, and anti-PDL1) in patients with More ... clinical trial drugs phase 1 monocentric C Dr. Hasna Bouchaab Boehringer Ingelheim International GmbH Centre Hospitalier Universitaire Vaudois, Lausanne
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) 14.08.2024
2024-00213 A RANDOMIZED, 2-ARM, PHASE 3 STUDY OF ELRANATAMAB (PF-06863135) VERSUS LENALIDOMIDE IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA AFTER UNDERGOING AUTOLOGOUS STEM-CELL TRANSPLANTATION clinical trial drugs phase 3 multicentric C Jeroen Goede Pfizer Pharma GmbH Kantonsspital Winterthur, Winterthur
Inselspital Bern, Universitätsklinik für Medizinische Onkologie, Bern
Zentrum für Onkologie/Hämatologie Kantonsspital Baden AG, Baden
Département d'oncologie UNIL- More ...
Kantonale Ethikkommission Zürich Ethikkommission Nordwest- und Zentralschweiz EKNZ, Kantonale Ethikkommission Bern, Kantonale Ethikkommission Zürich, Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) 07.05.2024
2024-00212 Testing the effectiveness of the culturally adapted skills training START NOW to reduce mental health problems in adolescent refugees clinical trial other clinical trials monocentric A Janine Bacher University Psychiatric Clinics Basel University Psychiatric Clinics Basel, Basel
Ethikkommission Nordwest- und Zentralschweiz EKNZ 13.03.2024 yes